Last reviewed · How we verify
Intra-Abdominal Anaerobic Abscess
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - Metro I.V. In Plastic Container · Baxter
- Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Intra-Abdominal Anaerobic Abscess patent landscape — cliff calendar, originator estates, attackable patents
- Intra-Abdominal Anaerobic Abscess treatment landscape brief
- Intra-Abdominal Anaerobic Abscess treatment updates RSS
Frequently asked questions about Intra-Abdominal Anaerobic Abscess
What drugs treat Intra-Abdominal Anaerobic Abscess?
Tracked treatments include Cleocin T, Cleocin, Metro I.V. In Plastic Container, Metronidazol.
What is the treatment for Intra-Abdominal Anaerobic Abscess?
Standard treatment for Intra-Abdominal Anaerobic Abscess includes Cleocin T, Cleocin, Metro I.V. In Plastic Container, Metronidazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Intra-Abdominal Anaerobic Abscess patent cliff · Intra-Abdominal Anaerobic Abscess CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Metronidazol · University of Oslo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing